SEROPREVALENCE OF T. cruzi INFECTION IN BLOOD DONORS AND CHAGAS CARDIOMYOPATHY IN PATIENTS FROM THE COAL MINING REGION OF COAHUILA, MEXICO

被引:4
|
作者
Martinez-Tovar, Jose Gerardo [1 ]
Rebollar-Tellez, Eduardo A. [2 ]
Salas, Ildefonso Fernandez [2 ]
机构
[1] Inst Mexicano Seguro Social, Hosp Gen Zona 24, Nueva Rosita, Coahuila, Mexico
[2] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Lab Entomol Med, San Nicolas De Los Garza 66400, Nuevo Leon, Mexico
关键词
Chagas disease; American trypanosomiasis; Trypanosoma cruzi; Chagasic cardiomyopathy; Coal mining region; Serology; Seroprevalence; ELISA; TRYPANOSOMA-CRUZI; NUEVO-LEON; DISEASE; TRANSMISSION; ANTIBODIES; TEXAS; PREVALENCE; TRIATOMINAE; REDUVIIDAE; PARASITE;
D O I
10.1590/S0036-46652014000200014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Context and Objective: Chagas disease is considered a worldwide emerging disease; it is endemic in Mexico and the state of Coahuila and is considered of little relevance. The objective of this study was to determine the seroprevalence of T. cruzi infection in blood donors and Chagas cardiomyopathy in patients from the coal mining region of Coahuila, Mexico. Design and Setting: Epidemiological, exploratory and prospective study in a general hospital during the period January to June 2011. Methods: We performed laboratory tests ELISA and indirect hemagglutination in three groups of individuals: 1) asymptomatic voluntary blood donors, 2) patients hospitalized in the cardiology department and 3) patients with dilated cardiomyopathy. Results: There were three levels of seroprevalence: 0.31% in asymptomatic individuals, 1.25% in cardiac patients and in patients with dilated cardiomyopathy in 21.14%. Conclusions: In spite of having detected autochthonous cases of Chagas disease, its importance to local public health remains to be established as well as the details of the dynamics of transmission so that the study is still in progress.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 21 条
  • [21] Highly purified CD34 positive peripheral blood stem cells for allografting of adult patients from unrelated donors: T cell add-back does not decrease the risk of infection and relapse.
    Bornhaeuser, M
    Theuser, C
    Ehninger, G
    Platzbecker, U
    BLOOD, 2001, 98 (11) : 672A - 673A